Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin. 1977

T D Bjornsson, and P J Meffin, and T F Blaschke

UI MeSH Term Description Entries
D008297 Male Males
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

T D Bjornsson, and P J Meffin, and T F Blaschke
August 1974, Clinical pharmacology and therapeutics,
T D Bjornsson, and P J Meffin, and T F Blaschke
September 1987, Clinical pharmacology and therapeutics,
T D Bjornsson, and P J Meffin, and T F Blaschke
March 1981, Clinical pharmacology and therapeutics,
T D Bjornsson, and P J Meffin, and T F Blaschke
April 1972, Thrombosis et diathesis haemorrhagica,
T D Bjornsson, and P J Meffin, and T F Blaschke
January 1980, The New England journal of medicine,
T D Bjornsson, and P J Meffin, and T F Blaschke
January 1982, Circulation,
T D Bjornsson, and P J Meffin, and T F Blaschke
March 1998, The Journal of pharmacology and experimental therapeutics,
T D Bjornsson, and P J Meffin, and T F Blaschke
January 1992, Drug metabolism and disposition: the biological fate of chemicals,
T D Bjornsson, and P J Meffin, and T F Blaschke
November 1953, The Journal of biological chemistry,
T D Bjornsson, and P J Meffin, and T F Blaschke
January 1984, Pharmacology,
Copied contents to your clipboard!